Director-linked entity trims 37,500 Establishment Labs (ESTA) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Establishment Labs Holdings Inc. director-related entity Sariel Group Ltd sold 37,500 Common Shares of ESTA on April 14, 2026 in an open‑market transaction at a weighted average price of $65.228 per share, within a range of $65.00 to $65.60, under a pre‑arranged Rule 10b5-1 trading plan.
Following the sale, Sariel Group Ltd held 1,182,504 Common Shares indirectly attributable to director Juan Jose Chacon Quiros, while he also held 45,193 Common Shares directly. He disclaims beneficial ownership of Sariel Group Ltd’s shares except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 37,500 shares ($2,446,050)
Net Sell
2 txns
Insider
Chacon Quiros Juan Jose
Role
Director
Sold
37,500 shs ($2.45M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 37,500 | $65.228 | $2.45M |
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 1,182,504 shares (Indirect, See Footnote);
Common Shares — 45,193 shares (Direct)
Footnotes (1)
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $65.00 to $65.60 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares are held by Sariel Group Ltd. The Reporting Person is a shareholder of Sariel Group Ltd and has voting and dispositive power over the shares owned by Sariel Group Ltd. The Reporting Person disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein.
Key Figures
Shares sold: 37,500 shares
Weighted average sale price: $65.228 per share
Sale price range: $65.00–$65.60 per share
+2 more
5 metrics
Shares sold
37,500 shares
Open-market sale on April 14, 2026
Weighted average sale price
$65.228 per share
Common Shares sold April 14, 2026
Sale price range
$65.00–$65.60 per share
Multiple trades comprising the 37,500-share sale
Indirect shares after sale
1,182,504 shares
Common Shares held by Sariel Group Ltd after transaction
Direct shares after transaction
45,193 shares
Common Shares directly held by Juan Jose Chacon Quiros
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, pecuniary interest, voting and dispositive power
4 terms
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
pecuniary interest financial
"disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein."
voting and dispositive power regulatory
"has voting and dispositive power over the shares owned by Sariel Group Ltd."
FAQ
What insider sale did Establishment Labs (ESTA) report in this Form 4?
An entity linked to director Juan Jose Chacon Quiros sold 37,500 Establishment Labs common shares. The sale occurred on April 14, 2026 at a weighted average price of $65.228 per share, in open‑market trades within a $65.00 to $65.60 price range.
Was the Establishment Labs (ESTA) insider sale made under a Rule 10b5-1 plan?
Yes, the sale was executed under a pre‑arranged Rule 10b5-1 trading plan adopted by the reporting person. Such plans schedule trades in advance, which can make the timing of sales appear more routine and less discretionary for the insider.
What are Juan Jose Chacon Quiros’s direct Establishment Labs (ESTA) holdings after this Form 4?
Following the reported transactions, Juan Jose Chacon Quiros directly held 45,193 Establishment Labs common shares. This direct position is separate from the 1,182,504 shares held indirectly through Sariel Group Ltd, which are reported with a beneficial ownership disclaimer.